According to a recent LinkedIn post from Glooko, the company’s team participated in the 38th Annual Diabetes Conference: Managing Diabetes Across the Lifespan in North Carolina. The post highlights that Glooko presented its inpatient and outpatient diabetes connected-care solutions, emphasizing potential benefits for health outcomes and clinical workflow efficiency.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The post suggests that Glooko is actively engaging with diabetes care professionals and academic stakeholders, including organizations such as the South Piedmont AHEC, MADCES, and the UNC Eshelman School of Pharmacy. For investors, this type of presence may support brand visibility, clinician adoption, and longer-term demand for the company’s digital health offerings in the diabetes management market.
By focusing on both inpatient and outpatient settings, the LinkedIn content implies that Glooko is positioning its platform as a comprehensive solution across the continuum of care. If this positioning translates into broader institutional uptake, it could enhance recurring revenue opportunities and strengthen the company’s competitive stance within diabetes technology and connected-care solutions.